Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC 4017.SR · SAR
Health Care · Tadawul · 🇸🇦 Saudi Arabia
29.94
-1.12%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Its shares trade on Tadawul under the ticker 4017.SR. It has been listed since 5 June 2024. In the fiscal year to 31 December 2025, it reported revenue of SAR 3.09bn and net income of SAR 290.2m. At that date it held total assets of SAR 5.83bn and shareholders' equity of SAR 3.17bn.
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is a SA-based company operating in Health Care Providers & Services industry. The company is headquartered in Jeddah, Makkah. The company went IPO on 2024-06-05. Dr. Soliman Fakeeh Hospital (DSFH) is a Saudi Arabia-based company. The firm is engaged in operating private hospitals and clinics. The company offers its medical services through six units: the Specialty Units, which include burn care unit, renal dialysis unit, extended care unit, In vitro fertilization lab, extra corporeal shock wave lithotripsy (ESWL Unit), hyperbaric oxygen unit, bone marrow transplant unit, organ transplantation center, allergy, immunology and respiratory and sleep disorders unit (AIRS Unit); Laboratory Unit, which includes pathology section, hematological diagnosis laboratory, toxicology and drug monitoring laboratory, microbiology laboratory and virology laboratory; Executive Health Program, which is a personalized health Program, offering a range of consultations, investigations and diagnostic procedures; Clinical Department, which includes internal medicine, obstetrics & gynecology, pediatrics, general surgery and anesthesia, among others; Pharmacy, and Radiology.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 5 Jun 2024
- Website
- en.dsfhjeddah.fakeeh.care ↗
Leadership
Pay as last reported
- Dr. Mazen FakeehPresident, since 2024
- Mr. Taimoor Ali SoomroChief Financial Officer
- Dr. Samar Assem BadreddinePresident - Quality Standards and Compliance, since 2023
- Dr. Sohail BajammalChief Executive Officer of Dr. Soliman Fakeeh Hospital, Jeddah
- Mr. Tamer Said AbdelgawadVice President - Operations
- Mr. Soliman Mazen FakeehMarketing and Business Development Director
- Ms. Sara Abdullah AlrumikhaniDirector - Patient Experience
- Dr. Anas Shaban BanahChief Medical and Nursing Officer
- Ms. Mai Mazen FakeehChief Operating Officer of Dr. Soliman Fakeeh Hospital, Jeddah, since 2024
- Mr. Musa Mohammad Musa AwadDirector - Supply Chain
- Ms. Khadra Mohamed OmarChief Nursing Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC operates six specialized units in Jeddah, Saudi Arabia.
- The company offers comprehensive medical services including burn care, renal dialysis, and organ transplantation.
- Dr. Soliman Fakeeh Hospital provides a personalized Executive Health Program for tailored medical consultations.
Weaknesses
- The company's IPO on 5 June 2024 marks its first public listing in the Health Care sector.
- Dr. Soliman Fakeeh Hospital operates exclusively within Jeddah, Makkah region.
- The company's business model focuses solely on private hospital and clinic operations.
Opportunities
- The Saudi Health Care sector is expanding with increased government investment in medical infrastructure.
- The growing demand for specialized medical services like organ transplantation and burn care presents opportunities.
- The Executive Health Program can attract high-net-worth individuals seeking personalized health solutions.
Threats
- The Health Care sector in Saudi Arabia faces regulatory changes that could impact operations.
- Competition from other private hospitals in Jeddah may affect market share.
- Economic fluctuations in Saudi Arabia could reduce patient volume for non-essential medical services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.